Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Vaccination for Patients With Immunosuppression and Altered Immunity: A Workgroup Report from the AAAAI Adverse Reactions to Drugs, Biologics, and Vaccines Committee and the Autoimmunity and Altered Immune Response Committee.

Created on 07 Jul 2026

Authors

Mildred Kwan, Blanka M Kaplan, Krista Shaw, Veronica Alix, Vishaka R Hatcher, Isma Shah, Donald S Levy, Maria Shabih, Allison E Norton, Aarti Pandya, Samuel M Pope, Surender K Vaswani, Howard M Rosenblatt, Sara Anvari, Jolan Walter, Maya Jerath, Huifang Linda Lu, Renata Engler, Karla E Adams

Published in

The journal of allergy and clinical immunology. In practice. Volume 14. Issue 7. Pages 1549-1561.

Abstract

Vaccination, a fundamental strategy for infectious disease prevention, presents unique challenges in individuals with altered immunity. These populations include individuals with inborn errors of immunity, autoimmune and inflammatory diseases, solid organ transplants, hematopoietic stem cell transplants, biologic and immunosuppressive therapies, and pregnancy. Despite concerns regarding variable vaccine responses, altered efficacy, and safety profiles, these groups remain under-represented in clinical trials. This review synthesizes current evidence on immunization outcomes in medically complex populations, highlighting strengths and limitations in existing research. We describe how altered immunity affects vaccine responses, summarize data on adverse reactions, and examine the influence of biologic therapies and pregnancy. Our analysis identifies significant gaps, including insufficient long-term durability data, inadequate safety surveillance for special populations, and limited incorporation of precision medicine approaches. We propose recommendations to address these deficiencies, including targeted vaccine trials for special populations, broader trial inclusion, enhanced outcome measures, refined safety monitoring, and tailored vaccine guidance. By advancing precision immunization strategies, clinicians and researchers can optimize vaccine protection for vulnerable groups, promoting equitable access and improving public health outcomes.

PMID:
42409458
Bibliographic data and abstract were imported from PubMed on 07 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement